Literature DB >> 8109586

Acute liver failure.

W M Lee1.   

Abstract

Acute liver failure is a multiorgan syndrome with dramatic clinical features and, often, a fatal outcome. It is characterized by the onset of coma and coagulopathy within 6 months, and usually in < 6 weeks, from onset of illness. Viral hepatitis, drug-related liver injury, and the alcohol-acetaminophen syndrome are the most common etiologies. Altered mental status accompanied by jaundice is a hallmark of acute liver failure. A unique feature is the evolution of increased intracranial pressure due to cerebral edema. The resulting cerebral ischemia and brainstem herniation account for approximately 50% of deaths in patients with acute liver failure. Mannitol therapy may successfully treat most patients with high intracerebral pressure. Most patients demonstrate features of the multiple organ failure syndrome, including a shock-like state, renal failure, and occasionally respiratory distress syndrome. Close monitoring of volume status is necessary, since administration of large quantities of fluid may be required. Infection is also common; most pathogens are gram-positive, and fungal infections are also seen. Because an optimum therapy for acute liver failure does not yet exist, liver transplantation should be considered early, before advanced levels of coma develop. Alternative, experimental treatment modalities include heterotopic liver grafting, administration of hepatocyte growth factor, use of an extracorporeal liver-assist device, and liver cell transplantation, but none of these has attained widespread use.

Entities:  

Mesh:

Year:  1994        PMID: 8109586     DOI: 10.1016/0002-9343(94)90183-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

Review 1.  Animal models of acute hepatic failure.

Authors:  T M Rahman; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  The beneficial effect of N-acetylcysteine and ciprofloxacin therapy on the outcome of ischemic fulminant hepatic failure.

Authors:  Nimer Assy; Hana Gefen; Sorina Schlesinger; Osamah Hussein
Journal:  Dig Dis Sci       Date:  2007-12       Impact factor: 3.199

Review 3.  Brain edema in acute liver failure: mechanisms and concepts.

Authors:  Kakulavarapu V Rama Rao; Arumugam R Jayakumar; Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2014-02-25       Impact factor: 3.584

Review 4.  Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Int       Date:  2011-10-01       Impact factor: 3.921

5.  An experimental animal model of fulminant hepatic failure in pigs.

Authors:  Kuhn Uk Lee; Long-xian Zheng; Yong Beom Cho; Ki-Ho Kim; Jongwon Ha; Kyung-Suk Suh; Sung Eun Jung
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

Review 6.  Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Res       Date:  2013-01-01       Impact factor: 3.996

Review 7.  Multimodal monitoring in neurointensive care.

Authors:  P J Kirkpatrick; M Czosnyka; J D Pickard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

8.  Functional genetics-directed identification of novel pharmacological inhibitors of FAS- and TNF-dependent apoptosis that protect mice from acute liver failure.

Authors:  A P Komarov; E A Komarova; K Green; L R Novototskaya; P S Baker; A Eroshkin; A L Osterman; A A Chenchick; C Frangou; A V Gudkov
Journal:  Cell Death Dis       Date:  2016-03-17       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.